Cargando…
Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study
BACKGROUND: The role of an episode of acute kidney injury (AKI) in long-term mortality among initial survivors of critical illness is controversial. We aimed to determine whether AKI is independently associated with decreased survival at 3 years among 30-day survivors of intensive care. RESULTS: We...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Paris
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127925/ https://www.ncbi.nlm.nih.gov/pubmed/27900737 http://dx.doi.org/10.1186/s13613-016-0218-5 |
_version_ | 1782470310924124160 |
---|---|
author | Mildh, Henriikka Pettilä, Ville Korhonen, Anna-Maija Karlsson, Sari Ala-Kokko, Tero Reinikainen, Matti Vaara, Suvi T. |
author_facet | Mildh, Henriikka Pettilä, Ville Korhonen, Anna-Maija Karlsson, Sari Ala-Kokko, Tero Reinikainen, Matti Vaara, Suvi T. |
author_sort | Mildh, Henriikka |
collection | PubMed |
description | BACKGROUND: The role of an episode of acute kidney injury (AKI) in long-term mortality among initial survivors of critical illness is controversial. We aimed to determine whether AKI is independently associated with decreased survival at 3 years among 30-day survivors of intensive care. RESULTS: We included 2336 30-day survivors of intensive care enrolled in the FINNAKI study conducted in seventeen medical–surgical ICUs in Finland during a 5-month period in 2011–2012. The incidence of AKI, defined by the Kidney Disease: Improving Global Outcomes criteria, was 34.6%, and 192 (8.3%) commenced RRT. The 3-year mortality among AKI patients was 23.5% (95% CI 20.6–26.4%) compared to 18.9% (17.0–20.9%) of patients without AKI, p = 0.01. However, after adjustments using Cox proportional hazards regression, AKI was not associated with decreased 3-year survival (HR 1.05; CI 95% 0.86–1.27), whereas advanced age, poor pre-morbid functional performance, and presence of several comorbidities were. Additionally, we matched AKI patients to non-AKI patients 1:1 according to age, gender, presence of severe sepsis, and a propensity score to develop AKI. In the well-balanced matched cohort, 3-year mortality among AKI patients was 136 of 662 (20.5%; 17.5–23.6%) and among matched non-AKI patients 143 of 662 (21.6%; 18.5–24.7%), p = 0.687. Neither AKI nor RRT was associated with decreased survival at 3 years in the sensitivity analyses that excluded patients (1) with chronic kidney disease, (2) with AKI not commenced renal replacement therapy (RRT), and (3) with estimated pre-admission creatinine, chronic kidney disease, or AKI stage 1. CONCLUSION: AKI was not an independent risk factor for 3-year mortality among 30-day survivors. Increased 3-year mortality among patients with AKI who survive critical illness may not be related to AKI per se, but rather to advanced age and pre-existing comorbidities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0218-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5127925 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Paris |
record_format | MEDLINE/PubMed |
spelling | pubmed-51279252016-12-19 Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study Mildh, Henriikka Pettilä, Ville Korhonen, Anna-Maija Karlsson, Sari Ala-Kokko, Tero Reinikainen, Matti Vaara, Suvi T. Ann Intensive Care Research BACKGROUND: The role of an episode of acute kidney injury (AKI) in long-term mortality among initial survivors of critical illness is controversial. We aimed to determine whether AKI is independently associated with decreased survival at 3 years among 30-day survivors of intensive care. RESULTS: We included 2336 30-day survivors of intensive care enrolled in the FINNAKI study conducted in seventeen medical–surgical ICUs in Finland during a 5-month period in 2011–2012. The incidence of AKI, defined by the Kidney Disease: Improving Global Outcomes criteria, was 34.6%, and 192 (8.3%) commenced RRT. The 3-year mortality among AKI patients was 23.5% (95% CI 20.6–26.4%) compared to 18.9% (17.0–20.9%) of patients without AKI, p = 0.01. However, after adjustments using Cox proportional hazards regression, AKI was not associated with decreased 3-year survival (HR 1.05; CI 95% 0.86–1.27), whereas advanced age, poor pre-morbid functional performance, and presence of several comorbidities were. Additionally, we matched AKI patients to non-AKI patients 1:1 according to age, gender, presence of severe sepsis, and a propensity score to develop AKI. In the well-balanced matched cohort, 3-year mortality among AKI patients was 136 of 662 (20.5%; 17.5–23.6%) and among matched non-AKI patients 143 of 662 (21.6%; 18.5–24.7%), p = 0.687. Neither AKI nor RRT was associated with decreased survival at 3 years in the sensitivity analyses that excluded patients (1) with chronic kidney disease, (2) with AKI not commenced renal replacement therapy (RRT), and (3) with estimated pre-admission creatinine, chronic kidney disease, or AKI stage 1. CONCLUSION: AKI was not an independent risk factor for 3-year mortality among 30-day survivors. Increased 3-year mortality among patients with AKI who survive critical illness may not be related to AKI per se, but rather to advanced age and pre-existing comorbidities. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13613-016-0218-5) contains supplementary material, which is available to authorized users. Springer Paris 2016-11-29 /pmc/articles/PMC5127925/ /pubmed/27900737 http://dx.doi.org/10.1186/s13613-016-0218-5 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Mildh, Henriikka Pettilä, Ville Korhonen, Anna-Maija Karlsson, Sari Ala-Kokko, Tero Reinikainen, Matti Vaara, Suvi T. Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
title | Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
title_full | Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
title_fullStr | Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
title_full_unstemmed | Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
title_short | Three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational FINNAKI study |
title_sort | three-year mortality in 30-day survivors of critical care with acute kidney injury: data from the prospective observational finnaki study |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127925/ https://www.ncbi.nlm.nih.gov/pubmed/27900737 http://dx.doi.org/10.1186/s13613-016-0218-5 |
work_keys_str_mv | AT mildhhenriikka threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT pettilaville threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT korhonenannamaija threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT karlssonsari threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT alakokkotero threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT reinikainenmatti threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT vaarasuvit threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy AT threeyearmortalityin30daysurvivorsofcriticalcarewithacutekidneyinjurydatafromtheprospectiveobservationalfinnakistudy |